BriaCell Therapeutics Corp - Warrant expiring 2026 — Cash Flow (NASDAQ:BCTXW)

Financials

Cash from operating activities -12.48 M-23.74 M-24.13 M-28.17 M -28.92 M Cash from investing activities ——-681.8 K-7.65 M -7.65 M Cash from financing activities -3.74 M3.95 M4.42 M45.45 M 33.49 M Free cash flow -12.48 M-23.74 M-24.58 M-28.17 M -28.92 M